Organization
SAES Getters SpA
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
SAES Getters SpA
... mobility solutions for millions of people, noted Lindsay Brooke, Editor in Chief. SAEs Autonomous Vehicle Engineering (AVE) magazine will deliver informed reporting and expert analysis ...
... 1.5x1012 CFU for 14 days. There have been no serious adverse events (SAEs), and no cases of infection with the bacteria in this study. While ...
... and infusion-related reactions (IRRs). The frequency of deaths and serious adverse events (SAEs) was similar in the patisiran and placebo groups. These data support the ...
... and infusion-related reactions (IRRs). The frequency of deaths and serious adverse events (SAEs) was similar in the patisiran and placebo groups. These data support the ...
... 30mg was well tolerated with no deaths, and a low incidence of SAEs (2.5% of IV meloxicam vs. 4.2% of placebo) and withdrawals due to ...
... data presented at AHS demonstrated that these results were attained with no SAEs and a favorable tolerability profile. M207 is designed to rapidly deliver zolmitriptan ...
... extension period, with rates of treatment-emergent adverse events (TEAEs), serious adverse events (SAEs), and discontinuations due to AEs that were consistent with rates seen in ...
... of a 135-to-1 reverse split of its issued and outstanding common stock. SAE's common stock will begin trading on a split-adjusted basis when the market ...
... a 135-to-1 reverse stock split, 6,497,979 newly issued shares (the "Shares") of SAE's common stock, upon the terms and subject to the conditions set forth ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤